Edition:
United States

Zoetis Inc (ZTS.N)

ZTS.N on New York Stock Exchange

70.79USD
17 Nov 2017
Change (% chg)

$0.38 (+0.54%)
Prev Close
$70.41
Open
$70.24
Day's High
$71.11
Day's Low
$70.24
Volume
592,365
Avg. Vol
615,274
52-wk High
$71.11
52-wk Low
$48.55

Chart for

About

Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock)... (more)

Overall

Beta: 1.01
Market Cap(Mil.): $34,309.96
Shares Outstanding(Mil.): 487.29
Dividend: 0.10
Yield (%): 0.60

Financials

  Industry Sector
P/E (TTM): -- 31.18 15.80
EPS (TTM): -- -- --
ROI: -- 15.02 12.07
ROE: -- 16.37 16.02

BRIEF-Zoetis Inc Q3 earnings per share $0.61

* Q3 earnings per share view $0.62 -- Thomson Reuters I/B/E/S

Nov 02 2017

BRIEF-Zoetis announces pricing of $1.25 bln of senior notes

* Zoetis Inc - ‍agreed to sell $1.25 billion of senior notes, consisting of $750 million aggregate principal amount of 3.000% senior notes due 2027​

Sep 05 2017

BRIEF-Immunovaccine announces achievement of milestones in collaboration with Zoetis to develop veterinary vaccines

* Immunovaccine announces achievement of milestones in collaboration with Zoetis to develop veterinary vaccines Source text for Eikon: Further company coverage:

Aug 31 2017

BRIEF-Anatara and Zoetis to negotiate terms of an international Detach commercial agreement

* Anatara and Zoetis to negotiate terms of an international Detach® commercial agreement Source text for Eikon: Further company coverage:

Aug 21 2017

BRIEF-Zoetis reports Q2 earnings per share $0.50

* Q2 earnings per share view $0.53 -- Thomson Reuters I/B/E/S

Aug 08 2017

BRIEF-High Court of Ireland approves acquisition of Nexvet by Zoetis Inc's unit

* High Court of Ireland has approved acquisition of Nexvet by Zoetis Inc through its unit Source text for Eikon: Further company coverage:

Jul 28 2017

Competitors

  Price Chg
Merck & Co., Inc. (MRK.N) $55.20 +0.03
Bayer AG (BAYGn.DE) €107.55 -0.35
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €75.43 -0.54
Eli Lilly and Co (LLY.N) $82.89 -0.55

Earnings vs. Estimates